| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.04 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.05 |